The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: December 2025

December 8, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.


8. Stromal lipid species dictate melanoma metastasis and tropism

  • 1. Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage
  • 2. PPP2R1A mutations portend improved survival after cancer immunotherapy
  • 3. Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness
  • 4. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
  • 5. Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy
  • 6. The source of dietary fat influences anti-tumour immunity in obese mice
  • 7. Nerve-to-cancer transfer of mitochondria during cancer metastasis
  • 8. Stromal lipid species dictate melanoma metastasis and tropism
  • 9. TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
  • 10. IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages
Previous
Next
Gurung, S. et al. Cell. 43(6): P1108-1124.E11. (2025).
doi: 10.1016/j.ccell.2025.04.001.

Summary of the findings

This study reveals a central role for stromal lipid availability in shaping melanoma metabolism, metastatic potential, and organ tropism, with clear age-related differences. Adipocytes from young skin contain and secrete more total lipids than aged adipocytes; melanoma cells take up and use these lipids, adjusting their consumption and oxidative phosphorylation (OxPhos). The resulting OxPhos state (higher in young-skin, lower in aged) sets metastatic pace and favours distinct destinations (lung, liver, or brain). Melanoma cells exposed to more lipids in young skin, leading to high OxPhos, are less metastatic, and more easily seed the lung. In contrast, melanoma in lipid-poor aged skin, leading to moderate OxPhos, rapidly metastasises to the liver. Age-specific lipid species taken up from the tumour microenvironment also activate cancer-cell–intrinsic signalling pathways critical for cancer–immunity interactions. In young skin, phosphatidylcholines drive PI3K/AKT and the OxPhos pathways; whereas in the aged skin, ceramides activate the S1P/IL6 and liver tropism. Blocking OxPhos, stromal lipid uptake or IL6 signalling impairs melanoma metastasis. Importantly, human visceral metastases to organs follow non-random pathways and are age-specific; and the time to progression to liver metastases, which particularly afflict the elderly, is shorter than the time to establish other solid organ metastases.

.

Future impact

This work enhances the view of “melanoma in old age” from a demographic observation to a mechanistic framework involving age-dependent tumour metabolism. Metabolic programmes, imposed by lipid nutrient availability at the primary site, impose the rate of metastasis and tropism. Impairing lipid uptake and blocking lipid oxidation are adjuvant rationales of care in young patients. Inhibiting ceramide-S1P-IL6 signalling pathway in melanoma cells in the aged microenvironment has the potential to limit metastatic spread to the liver.
.
Read more in Cell
.

8. Stromal lipid species dictate melanoma metastasis and tropism

  • 1. Long-Term Latency of Highly Mutated Cells in Normal Mouse Skin Is Reversed by Exposure to Tumor Promoters and Chronic Tissue Damage
  • 2. PPP2R1A mutations portend improved survival after cancer immunotherapy
  • 3. Neutrophils physically interact with tumor cells to form a signaling niche promoting breast cancer aggressiveness
  • 4. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer
  • 5. Impaired T cell and neoantigen retention in time-serial analysis of metastatic non-small cell lung cancer in patients unresponsive to TIL cell therapy
  • 6. The source of dietary fat influences anti-tumour immunity in obese mice
  • 7. Nerve-to-cancer transfer of mitochondria during cancer metastasis
  • 8. Stromal lipid species dictate melanoma metastasis and tropism
  • 9. TIM3+ breast cancer cells license immune evasion during micrometastasis outbreak
  • 10. IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages
Previous
Next

 

Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026

The EACR, AACR, and The Mark Foundation for Cancer Research recently teamed up to offer a number of travel grants to help EACR or AACR members...

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026

https://www.youtube.com/watch?v=KdMqmIIgNYo Click above to watch On 9 April 2026, the EACR hosted a free webinar bringing together leading experts to explore the Cancer Genome Interpreter (CGI)...

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

Patients Shaping Cancer Research – Episode 31 of The Cancer Researcher Podcast

April 13, 2026

What does it take to bridge the gap between researchers and patients? In this episode, scientists, oncologists, and patient advocates from Canada, the United States, and...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities
Community

“The best scientific event I have ever participated in”: Rafaela’s EACR Travel Grant leads to new opportunities

April 20, 2026
VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter
Features

VIDEO | Streamlining Tumour Interpretation with the Cancer Genome Interpreter

April 22, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR